524602 — Bandaram Pharma Packtech Income Statement
0.000.00%
Last trade - 00:00- IN₹459.36m
- IN₹631.84m
- IN₹340.79m
Annual income statement for Bandaram Pharma Packtech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 187 | 341 |
| Cost of Revenue | ||||
| Gross Profit | 0 | 0 | 26.8 | 65.3 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 0.316 | 0.1 | 180 | 320 |
| Operating Profit | -0.316 | -0.1 | 7.58 | 21.2 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.316 | -0.101 | 3.26 | 11.9 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.316 | -0.101 | 2.58 | 9.48 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.316 | -0.101 | 1.42 | 9.48 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.316 | -0.101 | 1.42 | 9.48 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.048 | -0.012 | 0.164 | 0.79 |
| Dividends per Share |